摘要
目的:通过对阳虚荷瘤小鼠不同治疗措施的干预结果观察,研究并探讨辨病、辨证、辨证辨病结合治疗对阳虚荷瘤小鼠的作用及其机理。方法:以氢化可的松和肝癌H22瘤株复制阳虚荷瘤小鼠复合模型,实验分模型对照组、辨证组、辨病组和辨证+辨病组,并设不加处理的空白对照组。各组分别在造模结束后第1至15天对其进行生存状态学观察;实验结束后检测各组动物抑瘤情况、IL-1、TNF-α水平。结果:①生存状态学观察结果显示:辨证组辨证辨病结合组动物的生存状态改善明显好于其他两组。②在抑肿瘤生长方面,辨证辨病结合组与对照组比较P<0.01,差异为极显著性;辨病组与对照组比较0.01<P<0.05,差异为显著性;而辨证组与对照组比较P>0.05,无统计学意义。③IL-1和TNF-α以辨证辨病结合组的上升幅度最大,辨证组居其次,但两者之间无统计学意义(P>0.05)。辨病组的上升幅度最小,且与前两组均有统计学意义(P<0.05)。结论:阳虚荷H22肝癌小鼠的复合动物模型是可以成功建立的。辨证结合辨病治疗是目前较为理想的中医治疗模式。从不同角度探索证型的实质,进一步丰富了证型的内涵,为证型治疗开拓了新思路。
Objectives: To observe the effect and investigate the possible mechanism of Chinese Medicine therapies in treating "Yang Qeficieney" with H22 hepatoma mice.Methods: The experimental mice models were produced by injecting Hydrocortisonum and H22 hepatoma cells.All animals were randomly divided into 5 groups.Each d them including 12 rats.The live states of rats were observed, the levels of IL- 1 and TNF- α in blood plasma were measured.Results: The live states of syndrome and syndrome/disease idfferentiation groups were obversely better than the other groups.The tumor inhibitory rate in syndrome/disease differentiation group was greatly higher than the control group ( P 〈 0.01 ) .The levels of IL-land TNF-α of blood plasma in syndrome/disease differentiation groups were higher than the other groups ( P 〈 0.05) .Conclusion: The experimental "Yang Qeficieney" with H22 hepatoma mice models were copied suceessfully.'The treatment of syndrome/disease differentiation is an ideal therapy.
出处
《四川中医》
2009年第10期20-22,共3页
Journal of Sichuan of Traditional Chinese Medicine
关键词
阳虚荷瘤模型
抑瘤率
IL-1
TNF-Α
"Yang Qeficiency" with H22 hepatoma mice models the rated inhibitory tumor IL-1 TNF-α